Neurology - Featured Archives - Insights

Phenotype-specific approach transcends traditional testing for autoimmune neurological conditions

Chris Bahnsen — Mon, 08 Jun 2026 13:00:00 +0000

Autoimmune neurology testing has evolved beyond limited paraneoplastic evaluations to phenotype-specific panels that identify clinically relevant antibodies. This phenotype-specific approach significantly improves diagnostic accuracy, reduces false positives, and helps guide faster, more personalized treatment for complex neurological diseases.

The post Phenotype-specific approach transcends traditional testing for autoimmune neurological conditions appeared first on Insights.

MOG-IgG as a marker of acute disseminated encephalomyelitis

Mayo Clinic Laboratories — Wed, 15 Apr 2026 13:00:00 +0000

Learn more about our CNS demyelinating disease testing through this case study focused on MOG-IgG as a marker of acute disseminated encephalomyelitis.

The post MOG-IgG as a marker of acute disseminated encephalomyelitis appeared first on Insights.

Multiple sclerosis: Diagnostic criteria update and kappa free light chain testing

Robin Huiras-Carlson — Tue, 14 Apr 2026 13:00:00 +0000

Mayo Clinic Laboratories’ MS testing cascade, which starts with kappa free light chain (KFLC) testing and reflexes to oligoclonal banding when indicated, is supported by the revised 2024 McDonald Criteria. This approach delivers faster, more definitive results, enabling earlier treatment decisions and improved patient outcomes.

The post Multiple sclerosis: Diagnostic criteria update and kappa free light chain testing appeared first on Insights.

Breakthrough Test Enhances Peripheral Neuropathy Care and Research

Mayo Clinic Laboratories — Thu, 05 Mar 2026 14:00:00 +0000

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to explore recent examples of diagnostic innovations that are improving patient care. Dr. Pritt also welcomes Matthew Schultz, Ph.D., a clinical biochemical geneticist at Mayo Clinic, to discuss how a novel test is delivering answers for patients with a recently identified peripheral neuropathy.

The post Breakthrough Test Enhances Peripheral Neuropathy Care and Research appeared first on Insights.

Alzheimer’s Disease Blood Biomarkers

MCL Education — Mon, 09 Feb 2026 12:00:00 +0000

This presentation offers a clear introduction to emerging blood based biomarkers for Alzheimer’s disease.

The post Alzheimer’s Disease Blood Biomarkers appeared first on Insights.

Rational Approaches to Testing in the MCI/Dementia Setting

MCL Education — Wed, 31 Dec 2025 12:00:00 +0000

In this video, Dr. Vijay Ramanan shares perspectives on rational approaches to testing in the cognitive neurology, mild cognitive impairment, and dementia settings.

The post Rational Approaches to Testing in the MCI/Dementia Setting appeared first on Insights.

Advancing precision diagnostics for neurodegenerative disorders

jgilligan1 — Tue, 25 Nov 2025 14:00:00 +0000

SAAmplify™-αSYN testing offers unprecedented accuracy in diagnosing Parkinson’s and Lewy body dementia.

The post Advancing precision diagnostics for neurodegenerative disorders appeared first on Insights.

Unraveling IgG4-related disease with coordinated diagnostic expertise

Chris Bahnsen — Mon, 17 Nov 2025 14:00:00 +0000

After months of misdiagnoses, Tom Heisler found answers at Mayo Clinic, where advanced renal pathology revealed IgG4-related disease and led to his recovery.

The post Unraveling IgG4-related disease with coordinated diagnostic expertise appeared first on Insights.

Join us on Oct. 29 for a SAAmplify-αSYN testing webinar

MCL Education — Mon, 08 Sep 2025 13:00:00 +0000

Join us for a webinar exploring the revolutionary way SAAmplify™–αSYN testing, which is offered by Mayo Clinic Laboratories in collaboration with Amprion, is improving diagnostic accuracy for patients with neurodegenerative disorders.

The post Join us on Oct. 29 for a SAAmplify-αSYN testing webinar appeared first on Insights.

Alzheimer’s Disease: Understanding CSF Biomarkers

MCL Education — Wed, 03 Sep 2025 10:00:00 +0000

Diagnostic advances allow earlier & more accurate detection of Alzheimer's using cerebrospinal fluid biomarkers.

The post Alzheimer’s Disease: Understanding CSF Biomarkers appeared first on Insights.